Michael Mazzeffi1, John Greenwood2, Kenichi Tanaka3, Jay Menaker2, Raymond Rector4, Daniel Herr2, Zachary Kon4, Joy Lee3, Bartley Griffith4, Keshava Rajagopal4, Si Pham4. 1. Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: mmazzeffi@anes.umm.edu. 2. Department of Shock Trauma Critical Care, University of Maryland School of Medicine, Baltimore, Maryland. 3. Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland. 4. Department of Cardiothoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: Bleeding may occur frequently during adult extracorporeal life support; however, there are no detailed investigations of bleeding events, red blood cell transfusion, and their impact on mortality. The purpose of our study was to characterize the incidence of bleeding and red blood cell transfusion during adult extracorporeal life support and examine the impact on mortality. METHODS: We performed a retrospective analysis of adult extracorporeal life support patients over approximately a 3-year period. The incidence of bleeding events and transfusions were recorded. Unadjusted and adjusted multivariate logistic regression analyses were performed to estimate the odds of inhospital mortality among patients with bleeding and for each red blood cell unit transfused. Ninety-day survival was compared between patients who bled and those who did not. RESULTS: Serious bleeding events occurred in 74 of 132 patients (56.1%), and the rate of bleeding was 10 events per 100 days. The crude odds ratio for inhospital mortality in patients who bled was 2.22 (95% confidence interval [CI]: 1.00 to 4.94, p = 0.05); and for each unit of red blood cells transfused, it was 1.03 (95% CI: 1.01 to 1.04, p = 0.005). The adjusted odds ratios for bleeding and red blood cell transfusions were 0.90 (95% CI: 0.37 to 2.19, p = 0.82) and 1.03 (95% CI: 1.00 to 1.06, p = 0.04). There was a trend toward decreased 90-day survival among patients who bled compared with patients who did not (46.7% versus 64.9%, p = 0.08). CONCLUSIONS: Bleeding and red blood cell transfusion occur frequently during adult extracorporeal life support, but only the amount of red blood cell transfusion is associated with inhospital mortality after controlling for confounding variables.
BACKGROUND:Bleeding may occur frequently during adult extracorporeal life support; however, there are no detailed investigations of bleeding events, red blood cell transfusion, and their impact on mortality. The purpose of our study was to characterize the incidence of bleeding and red blood cell transfusion during adult extracorporeal life support and examine the impact on mortality. METHODS: We performed a retrospective analysis of adult extracorporeal life support patients over approximately a 3-year period. The incidence of bleeding events and transfusions were recorded. Unadjusted and adjusted multivariate logistic regression analyses were performed to estimate the odds of inhospital mortality among patients with bleeding and for each red blood cell unit transfused. Ninety-day survival was compared between patients who bled and those who did not. RESULTS: Serious bleeding events occurred in 74 of 132 patients (56.1%), and the rate of bleeding was 10 events per 100 days. The crude odds ratio for inhospital mortality in patients who bled was 2.22 (95% confidence interval [CI]: 1.00 to 4.94, p = 0.05); and for each unit of red blood cells transfused, it was 1.03 (95% CI: 1.01 to 1.04, p = 0.005). The adjusted odds ratios for bleeding and red blood cell transfusions were 0.90 (95% CI: 0.37 to 2.19, p = 0.82) and 1.03 (95% CI: 1.00 to 1.06, p = 0.04). There was a trend toward decreased 90-day survival among patients who bled compared with patients who did not (46.7% versus 64.9%, p = 0.08). CONCLUSIONS:Bleeding and red blood cell transfusion occur frequently during adult extracorporeal life support, but only the amount of red blood cell transfusion is associated with inhospital mortality after controlling for confounding variables.
Authors: Ismael A Salas De Armas; Kha Dinh; Bindu Akkanti; Pushan Jani; Reshma Hussain; Lisa Janowiak; Kayla Kutilek; Manish K Patel; Mehmet H Akay; Rahat Hussain; Jayeshkumar Patel; Chandni Patel; Yafen Liang; John Zaki; Biswajit Kar; Igor D Gregoric Journal: J Extra Corpor Technol Date: 2020-12
Authors: Rei Ukita; Kan Wu; Xiaojie Lin; Neil M Carleton; Noritsugu Naito; Angela Lai; Chi Chi Do-Nguyen; Caitlin T Demarest; Shaoyi Jiang; Keith E Cook Journal: Acta Biomater Date: 2019-05-10 Impact factor: 8.947
Authors: Angela Lai; Caitlin T Demarest; Chi Chi Do-Nguyen; Rei Ukita; David J Skoog; Neil M Carleton; Kagya A Amoako; Patrick J Montoya; Keith E Cook Journal: Acta Biomater Date: 2019-04-03 Impact factor: 8.947
Authors: Jennifer A Muszynski; Ron W Reeder; Mark W Hall; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; Kathleen L Meert; J Michael Dean; Tammara Jenkins; Robert F Tamburro; Heidi J Dalton Journal: Crit Care Med Date: 2018-06 Impact factor: 7.598